Clene Stock Price, News & Analysis
Company Description
Clene (NASDAQ: CLNNW) is a publicly traded company in the Pharmaceutical Preparations sector.
CLNNW stock has declined 96.4% over the past year. Shares last traded at $0.0018.
On a trailing twelve-month basis, Clene reported revenue of $200K with net income of -$26.2M. The company operates at a net profit margin of -13086.5%.
This page provides a comprehensive overview of CLNNW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Clene (CLNNW) stock last traded at $0.0018. Over the past 12 months, the stock has lost 96.4%.
Latest News
SEC Filings
Clene has filed 5 recent SEC filings, including 3 Form 4, 2 Form 144. The most recent filing was submitted on April 1, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CLNNW SEC filings →
Financial Highlights
Clene generated $200K in revenue over the trailing twelve months, retaining a 78.5% gross margin, operating income reached -$23.1M (-11541.5% operating margin), and net income was -$26.2M, reflecting a -13086.5% net profit margin. The company generated -$18.5M in operating cash flow. With a current ratio of 0.83, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Clene (CLNNW) currently stands at 3.2 thousand shares, up 39.3% from the previous reporting period, representing 1.3% of the float. Over the past 12 months, short interest has increased by 3135%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Clene (CLNNW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CLNNW Company Profile & Sector Positioning
Clene (CLNNW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.